Option chain shows key data for RespireRx Pharma's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for RespireRx Pharma.

RespireRx Pharma (OTC:RSPI) Stock, Option Chain

RespireRx Pharmaceuticals Inc is engaged in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. The pipeline products of the company are dronabinol which is developed for the treatment of OSA (Obstructive Sleep Apnea), a form of sleep apnea; CX1739 for the treatment of chronic central sleep apnea; CX717 and CX1942 is an injectable dosage for respiratory depression or vaso-occlusive passes associated with sickle cell disease. The company also focuses on developing another class of compounds called ampakines for the treatment of various respiratory disorders.

Cannabis

News

Markets

RSPI

RespireRx Pharmaceuticals Inc. (OTCPK:RSPI), focused on the discovery and development of treatments to combat diseases caused by disruption of neuronal signaling, and ResolutionRx Ltd, an unlisted public Australian company, and a subsidiary of RespireRx on August 3, 2023, entered into a series of bilateral agreements intended to transfer the Re

RespireRx Transferes Its Pharmaceutical Cannabinoid Program To ResolutionRx

RespireRx Pharmaceuticals Inc. (OTCPK:RSPI) entered into a letter of intent with an Australia headquartered bespoke clinical research organization focused on cannabinoid and psychedelic clinical research.

Comments

RespireRx Pharma

RespireRx Pharma (RSPI) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell